CINC's logo.
Ticker Symbol: CINC

CinCor Pharma Inc

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001868734

Company Profile

CinCor Pharma Inc. is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. The companys focus is on cardiovascular, metabolic and kidney diseases. CinCor Pharma was founded by Jon Isaacsohn, M.D., and Catherine Pearce, DHSc, MBA, in 2018.

Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: Marc de Garidel
Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: -$0.14 ( -0.48%)
Days Range: $29.02 - $29.35
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change -0.48%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 43764323

Valuation

Market Cap: 127.2B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A